NCT06235047View on ClinicalTrials.gov

Liposomal Doxorubicin-containing Front-line Treatment in Elderly Patients With HL (HL-MVD)

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

January 1, 2023

Study Completion Date

January 8, 2024

Conditions
Classic Hodgkin Lymphoma
Trial Locations (1)

80131

Federico II University, Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT06235047 - Liposomal Doxorubicin-containing Front-line Treatment in Elderly Patients With HL (HL-MVD) | Biotech Hunter | Biotech Hunter